RSV Cases Rise Among Young Children, Infants
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
WEDNESDAY, Sept. 6, 2023 -- Doctors are seeing a spike in severe cases of respiratory syncytial virus (RSV) among young children in Florida and Georgia, U.S. health officials warned Tuesday.
The U.S. Centers for Disease Control and Prevention sent an advisory to doctors, noting that regional increases usually predict the beginning of RSV season, "with increased RSV activity spreading north and west over the following 2–3 months."
RSV infections can be quite serious in young children, leading to as many as 300 deaths in those younger than 5 years each year, according to the CDC. About 2 million doctor visits and 80,000 hospitalizations are also attributed to RSV in young kids. RSV-related hospitalizations in Georgia rose from 2 in 100,000 children ages 4 years and younger to 7 per 100,000 between Aug. 5 and Aug. 19, according to the CDC. Most of these hospitalizations were in infants.
A new RSV shot called Beyfortus (nirsevimab) has been approved to help prevent infection in babies and at-risk toddlers. The monoclonal antibody is intended for infants younger than 8 months of age. At-risk children can get a second shot up to about 1.5 years old. The U.S. Food and Drug Administration has also approved an RSV vaccine for pregnant women, meant to protect their newborns during the first six months of life.
More Information
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.